drugset / Trial / NCT02147925
Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is to explore the effectiveness of liraglutide combined with metformin in non-alcoholic fatty-liver disease patients with type 2 diabetes mellitus (T2DM) compared to sitagliptin and insulin glargine in combination with metformin.
Timeline
- Start
- 2014-08
- Primary completion
- 2017-04
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Liraglutide | Peptide | 1.8 mg | — |
| Comparator | Sitagliptin | Small molecule | 100 mg | — |
| Comparator | insulin glargine | Protein / enzyme biologic | 0.2 iu/kg | — |
| Comparator | Metformin | Small molecule | — | — |